Center for Proteomics and Bioinformatics:
Ms. Schlatzer has over 15 years of analytical chemistry experience in both clinical and research environments. At Magellan Laboratories and GlaxoSmithKline, Ms. Schlatzer developed and managed both small molecule (SRM, MRM analysis) and large molecule (protein/peptide analysis) biomarker discovery efforts in clinical studies. Prior to her position in the Center for Proteomics and Bioinformatics, Ms. Schlatzer was a Senior Research Scientist at GlaxoSmithKline for seven years conducting proteomic research in disease and biomarker discovery. Her responsibilities included: method development for proteomic assays and project management of biomarker discovery efforts. In Ms. Schlatzer's current position, she has implemented a label free protein expression analysis platform for biomarker discovery in support of clinical proteomic studies. She provides project management and consulting services regarding experimental design for discovery and verification analysis as well as project plan development to research clinicians within the university and external collaborators. Her current clinical collaborations are in oncology, diabetes and cardiovascular research.